Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q4 FY22 results · Jan–Mar 2022
Caplin Point Laboratories reported revenue from operations of ₹339.24 crore (up 21.7% from Q4 FY21) and net profit of ₹80.83 crore (up 19.0% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 339.24 | 278.71 | +21.7% | 326.20 | +4.0% |
| Other income | 11.51 | 9.46 | +21.7% | 9.54 | +20.6% |
| Total income | 350.75 | 288.17 | +21.7% | 335.74 | +4.5% |
| Profit before tax | 99.92 | 84.97 | +17.6% | 98.66 | +1.3% |
| Net profit for the period | 80.83 | 67.92 | +19.0% | 79.28 | +2.0% |
| EPS, basic (₹) | 10.43 | 8.78 | +18.8% | 9.90 | +5.4% |
| Net margin (%) | 23.8 | 24.4 | 24.3 |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 111.94 | 122.88 | −8.9% | 128.22 | −12.7% |
| Other income | 10.26 | 7.36 | +39.4% | 8.54 | +20.1% |
| Total income | 122.20 | 130.24 | −6.2% | 136.76 | −10.6% |
| Profit before tax | 41.70 | 44.64 | −6.6% | 55.69 | −25.1% |
| Net profit for the period | 29.02 | 31.49 | −7.8% | 39.12 | −25.8% |
| EPS, basic (₹) | 3.83 | 4.16 | −7.9% | 5.17 | −25.9% |
| Net margin (%) | 25.9 | 25.6 | 30.5 |
Consolidated
- Filed with BSE
- 13 May 2022, 14:44 IST
- Board meeting
- 12 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 May 2022, 14:44 IST
- Board meeting
- 12 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE